Diana Ernst, RPh

Researchers investigated the contraceptive efficacy of the Copper IUD through 3 years of use, as assessed by the Pearl Index. The investigation is ongoing and effectiveness through 5 years will be later assessed.

The FDA has approved Lexapro for both pediatric and adult patients for the treatment of generalized anxiety disorder.

The FDA has approved Rexulti (brexpiprazole) for the treatment of agitation associated with dementia due to Alzheimer disease.

Uzedy is a subcutaneous, long-acting formulation of risperidone, an atypical antipsychotic.

Lumryz is an extended-release formulation of sodium oxybate.

The Nicotrol Inhaler (nicotine inhalation system) has been discontinued by Pfizer.

Abilify Asimtufii is intended for dosing every 2 months via intramuscular injection in the gluteal muscle.

Teva Pharmaceuticals is recalling certain lots of Fentanyl Buccal Tablets CII because safety updates were omitted in the product insert/medication guide.

If approved, brexpiprazole would be the first medication indicated for AAD in the US.

A warning about opioid-induced hyperalgesia has been added to the prescribing information.

Using a tetherless, adhesive fingertip sensor, the device monitors several physiological markers to detect the impairment of oxygenation due to opioid use.

If approved, Opill would be the first daily oral contraceptive pill available without a prescription.

This age group is now eligible to receive the booster dose at least 2 months after they complete primary vaccination with 3 doses of the monovalent vaccine.

Fasedienol (PH94B) is a first-in-class, rapid-onset investigational pherine nasal spray.

The test aids in the diagnosis of symptomatic or asymptomatic infections with C. trachomatis, N. gonorrhoeae, and T. vaginalis.

To better understand the new phenomenon of “patient influencers,” the authors conducted interviews with individuals who routinely offer advice on health topics on social media.

In 2011, following reports of serious livery injury, the FDA had required manufacturers of prescription acetaminophen combination products to limit the amount of acetaminophen to 325 mg per tablet or capsule.

Eplontersen is an investigational ligand-conjugated antisense medicine.

Aponvie is an injectable emulsion formulation of aprepitant.

Results showed vaccine efficacy of 83.7% against RSV-LRTD, defined by 2 or more symptoms.

Seena Fazel of the University of Oxford, UK, and colleagues at the Karolinska Institute in Sweden compared the medicated and nonmedicated periods of over 1.4 million beta blocker users.

Donanemab is an antibody therapy that targets a modified form of deposited amyloid-β peptide called N3pG.

The updated recommendations include both nonpharmacologic and pharmacologic interventions for adults in the acute phase of MDD.

The approval was based on data from 2 trials in adults who met DSM-IV-TR or DSM-5 criteria for MDD and had an inadequate response to 1 to 3 courses of prior antidepressant therapy.

The AAP has released a new list of 5 tests and procedures commonly ordered in pediatric emergency medicine that physicians and patients should question.

Xylazine is centrally-acting alpha2-adrengeric agonist that was originally approved in 1972 as a sedative and analgesic for use in veterinary medicine.

Lecanemab is a humanized monoclonal antibody that works by selectively binding to, neutralizing and eliminating soluble toxic amyloid beta aggregates.

An individual is considered fully vaccinated about 2 weeks after the second dose of Jynneos and 4 weeks after receiving ACAM2000.

Evusheld is a combination of 2 long-acting monoclonal antibodies designed to bind to distinct sites on the SARS-CoV-2 spike protein.

NVX-CoV2373 is engineered from the genetic sequence of SARS-CoV-2 using the Company’s recombinant nanoparticle technology to generate antigen derived from the coronavirus spike (S) protein.